This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When we first began this company, we had dreamed of harnessing technology to actually prevent disease, not just detect it," saidPeeyush Shrivastava, Co-Founder and CEO. What we've been doing with cancer for the past two decades, I see no reason why we can't do with heart disease."
Therefore, the ability to detect cardiac amyloidosis early is critical,” noted Jonathan Wall , PhD, director of the Amyloidosis and Cancer Theranostics Program and professor at the University of Tennessee Graduate School of Medicine in Knoxville, Tennessee.
At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury. The Feinstein Institutes for Medical Research is the global scientific home of bioelectronic medicine , which combines molecular medicine, neuroscience, and biomedical engineering.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
The scanner incorporates Philips’ unique Smart Reading technology, a cloud-based AI toolset that integrates imaging and reading on the MR scanner. Using Philips BlueSeal technology, MRT Praxis Potsdam in Germany, has realized an increase in patient throughput from 32-35 to 40 patients per day [5].
Such support is provided by a number of government institutions and charities, including the Medical Research Council, National Institute for Health and Care Research, Department of Health and Social Care, British Heart Foundation, Cancer Research UK and Wellcome. I don’t think so. I have read some utter bollocks in my life.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content